Traitements3programmes
Essais2liés
Publications0liées
SourceDBlocale

Traitements

3
MoléculeIndication / populationPhaseObjectifPaysRésultat
Focal irreversible electroporation of the prostate cancerThe purpose of this study is to evaluate safety and short-term oncological efficacy of the NanoKnife Irreversible Electroporation System for localised prostate cancer. Irreversible electroporation (IRE) is the method of focal treatment for prostate cancer, which is already proven by FDA as method of the surgical ablation of soft tissue. It has not received clearance for the therapy or treatment of any specific disease or condition. Cancer Non applicable À vérifier Russia À vérifier
Focal irreversible electroporation of the prostate cancerThe purpose of this study is to evaluate safety and short-term oncological efficacy of the NanoKnife Irreversible Electroporation System for localised prostate cancer. Irreversible electroporation (IRE) is the method of focal treatment for prostate cancer, which is already proven by FDA as method of the surgical ablation of soft tissue. It has not received clearance for the therapy or treatment of any specific disease or condition. Cancer Non applicable À vérifier Russia À vérifier
Focal irreversible electroporation of the prostate cancerThe purpose of this study is to evaluate safety and short-term oncological efficacy of the NanoKnife Irreversible Electroporation System for localised prostate cancer. Irreversible electroporation (IRE) is the method of focal treatment for prostate cancer, which is already proven by FDA as method of the surgical ablation of soft tissue. It has not received clearance for the therapy or treatment of any specific disease or condition. Cancer Non applicable À vérifier Russia À vérifier

Essais cliniques

2
MoléculeIndication / populationPhaseNCTTitreStatut
Focal irreversible electroporation of the prostate cancer Cancer Non applicable NCT03504995 Efficacy and Safety Assessment of IRE of Localized Prostate Cancer. COMPLETED
Focal irreversible electroporation of the prostate cancer Cancer Non applicable NCT04192890 Efficacy and Safety Assessment of IRE of Localized Prostate Cancer UNKNOWN

Publications

0
MoléculeIndication / populationTitreJournalDate
Aucune publication.